Articles dans des revues avec comité de lecture (396)
266.
Zielinski, C. C., Awada, A., Cameron, D. A., Cufer, T., Martin, M., & Aapro, M. (2008). The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients. European journal of cancer, 44(3), 353-365. doi:10.1016/j.ejca.2007.11.024267.
Awada, A., Cardoso, F., Fontaine, C., Dirix, L. Y., De Greve, J., Sotiriou, C., Steinseifer, J., Wouters, C., Tanaka, C., Zoellner, U., Tang, P., & Piccart-Gebhart, M. (2008). The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics. European journal of cancer, 44(1), 84-91. doi:10.1016/j.ejca.2007.10.003268.
Dequanter, D., Lothaire, P., Lemort, M., Canizares, P. A. C., Lalami, Y., & Awada, A. (2008). Intérêt du scanner thoracique dans le bilan initial et le suivi des patients traités pour un cancer des voies aérodigestives supérieures. Revue de laryngologie, d'otologie et de rhinologie, 129(4-5), 273-276.269.
Andersson, M., Awada, A., Barrett-Lee, P., Ellis, P., Hupperets, P., Jackisch, C., Kubista, E., Luck, H. J., Monerat, C., Nitz, U., & Untch, M. (2008). European oncologists preferences for the management of breast cancer: case presentations and expert commentary. Breast, 17(2), 1-11.272.
Van Nooten, F., Dewilde, S., Marbaix, S., Van Belle, S., Sautois, B., Awada, A., Focan, C., Verhoeven, D., & Gil, T. (2008). An economic approach of metastatic renal cell carcinoma (mRCC) in Belgium. Acta Clinica Belgica (English ed. Printed).273.
Wildiers, H., Sonet, A., Neefs, A., Elaheebux, M., Borghuys, W., Awada, A., & Dirix, L. (2008). Consensus text on the utilization of dexrazonane (Savene®) in anthracycline extravasation. Belgian journal of medical oncology, 2(2).275.
Vos, B., Gallez, J., Debroux, S., Roland, S., Verhest, A., Van Houtte, P., Awada, A., & Hendlisz, A. (2008). Concomitant chemo-radiotherapy as standard therapy in limited-stage small-cell oesophageal cancer: a summary of 3 clinical cases and review of the literature. Acta gastro-enterologica Belgica (Ed. multilingue), 71(3), 325-329.